Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Joergen Rungby"'
Autor:
SASHA KJELDSEN, NICOLE J. JENSEN, MALIN NILSSON, NIKLAS HEINZ, JANUS D. NYBING, FREDERIK H. LINDEN, ERIK HØGH-SCHMIDT, MIKAEL P. BOESEN, STEN MADSBAD, HENDRIK VILSTRUP, FRANK V. SCHIØDT, ANDREAS MØLLER, ELIAS B. RASHU, LISE GLUUD, STEEN B. HAUGAARD, JENS J. HOLST, JOERGEN RUNGBY, NICOLAI J. WEWER ALBRECHTSEN
Publikováno v:
Diabetes. 71
Glucagon is essential for glucose control and increased levels of glucagon (hyperglucagonemia) observed in patients with type 2 diabetes contribute to their hyperglycemia. Recently, hyperglucagonemia has also been found in individuals with non-alcoho
Autor:
Marit E. Jørgensen, Hanne Rolighed Christensen, Gregers S. Andersen, Vanja Kosjerina, Joergen Rungby, Birgitte Brock, Bendix Carstensen
Publikováno v:
Diabetes. 70
In the elderly population with type 2 diabetes (T2D), decisions about discontinuation of medication is important, as it may lead to improved outcomes and reduced polypharmacy-associated adverse events. However, the extent, patterns and secular change
Autor:
Jens J. Holst, Thomas Larsen, Jan Frystyk, Faidon Magkos, Mads N. Thomsen, Steen B. Haugaard, Arne Astrup, Bolette Hartmann, Nicole Jacqueline Jensen, Sten Madsbad, Kamilla W. Miskowiak, Thure Krarup, Mads J. Skytte, Helena Zander Wodschow, Joergen Rungby, Amirsalar Samkani
Publikováno v:
Diabetes. 70
Objective: We aimed to evaluate the effect of weight loss induced by a carbohydrate-reduced high-protein (CRHP) diet on physical and mental health and cognition. Methods: In this randomized parallel trial, 72 adults with type 2 diabetes and overweigh
Autor:
Joergen Rungby, Janus Damm Nybing, Nicolai J. Wewer Albrechtsen, Sasha A.S. Kjeldsen, Elias Badal Rashu, Hendrik Vilstrup, Jens J. Holst, Steen B. Haugaard, Sten Madsbad, Frederik H. Linden, Erik Høgh-Schmidt, Nicole Jacqueline Jensen, Lise Lotte Gluud, Malin Nilsson, Mikael Boesen
Publikováno v:
Diabetes. 70
Glucagon regulates hepatic glucose production and hyperglucagonemia contributes to diabetes. Equally important, glucagon may regulate amino acid (AA) levels that in turn control glucagon secretion. Hepatic steatosis may uncouple glucagon’s effect o
Autor:
Joern Jensen, J Sonne, Birgitte Brock, Dorthe Krogsgaard Bonnerup, Marianne Lisby, Maren-Lis Larsen, Joergen Rungby, Lars Peter Nielsen, Pernille Axelsen Gregersen, Jan Mainz
Publikováno v:
Lisby, M, Bonnerup, D K, Brock, B, Gregersen, P A, Jensen, J, Larsen, M-L, Rungby, J, Sonne, J, Mainz, J & Nielsen, L P 2018, ' Medication Review and Patient Outcomes in an Orthopedic Department : A Randomized Controlled Study ', Journal of Patient Safety, vol. 14, no. 2, pp. 74–81 . https://doi.org/10.1097/PTS.0000000000000173
Lisby, M, Bonnerup, D K, Brock, B, Gregersen, P A, Jensen, J, Larsen, M-L, Rungby, J, Sonne, J, Mainz, J & Nielsen, L P 2015, ' Medication Review and Patient Outcomes in an Orthopedic Department : A Randomized Controlled Study ', Journal of Patient Safety . https://doi.org/10.1097/PTS.0000000000000173
Lisby, M, Bonnerup, D K, Brock, B, Gregersen, P A, Jensen, J, Larsen, M-L, Rungby, J, Sonne, J, Mainz, J & Nielsen, L P 2015, ' Medication Review and Patient Outcomes in an Orthopedic Department : A Randomized Controlled Study ', Journal of Patient Safety . https://doi.org/10.1097/PTS.0000000000000173
OBJECTIVE: We investigated the health-related effect of systematic medication review performed by a clinical pharmacist and a clinical pharmacologist on nonelective elderly orthopedic patients.METHODS: This is a nonblinded randomized controlled study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d75ff9a69b4a3e27e25adf1eaafe5592
https://vbn.aau.dk/da/publications/650da506-5fd4-4d79-aa00-a722aa0d02fd
https://vbn.aau.dk/da/publications/650da506-5fd4-4d79-aa00-a722aa0d02fd
Autor:
Aage Vølund, Niels Møller, Joergen Rungby, Ole Schmitz, Lars Peter Sørensen, Birgitte Brock, Søren Nielsen, A. Mengel
Publikováno v:
Diabetic Medicine. 27:830-837
Diabet. Med. 27, 830–837 (2010) Abstract Aims Two long-acting insulin analogues, insulin glargine and insulin detemir, have been developed as alternatives to neutral protamine Hagedorn (NPH) insulin, which has been the preferred basal insulin prepa
Autor:
Birgitte Brock, Niels Moeller, Ole Schmitz, Liselotte Soendergaard, Joergen Rungby, Susanne Lerche, Jens J. Holst
Publikováno v:
Clinical Endocrinology. 71:500-506
Summary Objective It is uncertain whether the ability to avoid hypoglycaemia during fasting is preserved, and the risk of reactive hypoglycaemia after an oral glucose stimulus following a prolonged fasting period is increased at augmented glucagon-li
Publikováno v:
Ageing Research Reviews. 7:301-305
Insulin is released in a pulsatile manner, which results in oscillatory concentrations in blood. The oscillatory secretion improves release control and enhances the hormonal action. Insulin oscillates with a slow ultradian periodicity (approximately
Autor:
Susanne, Lerche, Liselotte, Soendergaard, Joergen, Rungby, Niels, Moeller, Jens Juul, Holst, Ole E, Schmitz, Birgitte, Brock
Publikováno v:
Clinical endocrinology. 71(4)
It is uncertain whether the ability to avoid hypoglycaemia during fasting is preserved, and the risk of reactive hypoglycaemia after an oral glucose stimulus following a prolonged fasting period is increased at augmented glucagon-like peptide-1 (GLP-
Autor:
Grethe Jakobsen, Birgitte Brock, Bernard R. Landau, Kristine B. Degn, Claus B. Juhl, Jeppe Sturis, V. Chandramouli, Joergen Rungby, Ole Schmitz
Publikováno v:
Degn, K B, Juhl, C B, Sturis, J, Jakobsen, G, Brock, B, Chandramouli, V, Rungby, J, Landau, B R & Schmitz, O 2004, ' One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and α-and β-cell function and reduces endogenous glucose release in patients with Type 2 diabetes ' Diabetes, vol. 53, pp. 1187-1194 .
Glucagon-like peptide 1 (GLP-1) is potentially a very attractive agent for treating type 2 diabetes. We explored the effect of short-term (1 week) treatment with a GLP-1 derivative, liraglutide (NN2211), on 24-h dynamics in glycemia and circulating f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6572863a320a3ca5b65dd6480d61ea2
https://pure.au.dk/portal/da/publications/one-weeks-treatment-with-the-longacting-glucagonlike-peptide-1-derivative-liraglutide-nn2211-markedly-improves-24h-glycemia-and--and-cell-function-and-reduces-endogenous-glucose-release-in-patients-with-type-2-diabetes(6dcdfcd0-1b0a-11da-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/one-weeks-treatment-with-the-longacting-glucagonlike-peptide-1-derivative-liraglutide-nn2211-markedly-improves-24h-glycemia-and--and-cell-function-and-reduces-endogenous-glucose-release-in-patients-with-type-2-diabetes(6dcdfcd0-1b0a-11da-bee9-02004c4f4f50).html